Skip to content

Comparison the effects and complications of paracetamol versus fentanyl for postoperative pain , patient satisfaction after cataract surgery under topical anesthesia

Comparison the effects and complications of paracetamol versus fentanyl for postoperative pain , and patient satisfaction after cataract surgery under topical anesthesia in Farabi Eye Hospital Tehran, Iran in 2011-2012

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012120511676N1
Enrollment
160
Registered
2013-03-04
Start date
2013-02-18
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sedation, complication, cataract. Senile incipient cataract Senile cataract: coronary cortical punctate Subcapsular polar senile cataract (anterior)(posterior) Water clefts

Interventions

Intervention 1: Group 1 or intervention group or p: all participants were given midazolam 0.015 mg/kg and tetracain eye drop 2 drops in each eyes with interval of 5 minutes. Administered paracetamol (
Treatment - Drugs
Group 1 or intervention group or p: all participants were given midazolam 0.015 mg/kg and tetracain eye drop 2 drops in each eyes with interval of 5 minutes. Administered paracetamol (15 mg/kg) 1 g /
Group2 or control group or F : all participants were given midazolam 0.015 mg/kg and tetracain eye drop 2 drops in each eyes with interval of 5 minutes. Administered fentanyl (1 µg/kg) in 100 cc norma

Sponsors

Vice chancellor for Research, Tehran University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:. American Society of Anesthesiology=1-2; age=50-80 years and first time cataract surgery. Exclusion criteria: addiction; psychological diseases; anxiety; existence of previous pain; sever allergic reaction; uncontrolled hepatic, renal and cardiovascular disease; neurologic disease;uncontrolled Diabetes Melitus disease and analgesic and sedative usage.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Heart rate. Timepoint: Before sedation 3 times, 3 min after sedation 3 times. Method of measurement: Monitoring full parameter pyandehgan company.;Saturation arteial o2. Timepoint: Before sedation 3 times, 3 min after sedation 3 times. Method of measurement: Pulse oximetry.;Pain. Timepoint: Before sedation, recovery. Method of measurement: VAS score.;Mean arterial presure. Timepoint: Before sedation 3 times, 3 min after sedation 3 times. Method of measurement: Monitoring full parameter pyandehgan company.;Satisfaction. Timepoint: At the recovery room. Method of measurement: Score 0-10, 0=absent satisfaction, 10= max satisfaction.

Secondary

MeasureTime frame
Apnea. Timepoint: During surgery. Method of measurement: Respiratory rate = 0.;Arrhythmia. Timepoint: During surgery. Method of measurement: Cardiac monitoring full parameter poyandehgan company.;Nausea and vomiting. Timepoint: At the recovery room. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmaryam jamshidi

Tehran University of Medical Sceinces

dr.mjamshidi@yahoo.com+98 21 8891 5353

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026